Skip to main content
Clinical Medicine logoLink to Clinical Medicine
. 2001 Nov 1;1(6):472–477. doi: 10.7861/clinmedicine.1-6-472

Cardiovascular risk reduction in diabetes: underemphasised and overdue. Messages from major trials

Amanda I Adler 1,
PMCID: PMC4953875  PMID: 11792088

Abstract

Diabetes markedly increases the risk of coronary artery disease and death, but is underrecognised as a cardiovascular risk factor, despite the existence of effective treatments. Because patients with diabetes are at high risk for coronary disease, they have more to gain from prevention. There is evidence from clinical trials that select cardiovascular therapies may work better in diabetes, beyond their expected benefit, and may prevent diabetes itself.

Full Text

The Full Text of this article is available as a PDF (149.6 KB).


Articles from Clinical Medicine are provided here courtesy of Royal College of Physicians

RESOURCES